Organ preservation in bladder cancer: an opportunity for truly personalized treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Organ preservation in bladder cancer: an opportunity for truly personalized treatment
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-13
DOI
10.1038/s41585-019-0199-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MRE11 as a predictive biomarker of outcome following radiotherapy in bladder cancer
- (2019) Alexandra K. Walker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Health-related quality of life after treatment for bladder cancer in England
- (2018) Samantha J Mason et al. BRITISH JOURNAL OF CANCER
- Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy
- (2018) Homayoun Zargar et al. JOURNAL OF UROLOGY
- Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer
- (2018) Alejandro Sanchez et al. JOURNAL OF UROLOGY
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
- (2018) Thomas Powles et al. LANCET
- Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma
- (2018) Min Yuen Teo et al. UROLOGIC CLINICS OF NORTH AMERICA
- Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer
- (2018) Stephen B. Williams et al. JAMA Surgery
- Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial
- (2018) John J. Coen et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
- (2018) Andrea Necchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
- (2017) Nicholas J. Giacalone et al. EUROPEAN UROLOGY
- Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment
- (2017) Shaista Hafeez et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists
- (2017) Abhishek A. Solanki et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer
- (2017) Catherine Thompson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)
- (2017) M. Dror Michaelson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
- (2017) Girish S. Kulkarni et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
- (2017) Arlene Siefker-Radtke et al. Nature Reviews Urology
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers
- (2017) Kentaro Nishioka et al. Radiation Oncology
- Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy
- (2017) Renate Pichler et al. Journal of Cancer
- Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer
- (2016) Kimberley S. Mak et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer
- (2016) Anne Vestergaard et al. RADIOTHERAPY AND ONCOLOGY
- Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I–II trials
- (2016) Orazio Caffo et al. RADIOTHERAPY AND ONCOLOGY
- MRI-guided prostate adaptive radiotherapy – A systematic review
- (2016) A.J. McPartlin et al. RADIOTHERAPY AND ONCOLOGY
- The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development
- (2016) Linda G. W. Kerkmeijer et al. Frontiers in Oncology
- Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
- (2015) N. Joseph et al. ANNALS OF ONCOLOGY
- A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)
- (2015) Giorgio Arcangeli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials
- (2015) G. Arcangeli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
- (2015) Cora N Sternberg et al. LANCET ONCOLOGY
- Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer
- (2015) Wei-Ching Lin et al. Translational Oncology
- Urinary Bladder Preservation for Muscle-invasive Bladder Cancer: A Survey among Radiation Oncologists of Lombardy, Italy
- (2015) Barbara Alicja Jereczek-Fossa et al. TUMORI
- Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
- (2015) Elisabeth E. Fransen van de Putte et al. WORLD JOURNAL OF UROLOGY
- Urinary Bladder Preservation for Muscle-invasive Bladder Cancer: A Survey among Radiation Oncologists of Lombardy, Italy
- (2015) Barbara Alicja Jereczek-Fossa et al. TUMORI JOURNAL
- Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer
- (2014) Anne Vestergaard et al. ACTA ONCOLOGICA
- Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer
- (2014) B A Hunter et al. BRITISH JOURNAL OF CANCER
- Curative Therapy for Bladder Cancer in Routine Clinical Practice: A Population-based Outcomes Study
- (2014) C.M. Booth et al. CLINICAL ONCOLOGY
- Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
- (2014) Guillaume Ploussard et al. EUROPEAN UROLOGY
- Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
- (2014) Raymond H. Mak et al. JOURNAL OF CLINICAL ONCOLOGY
- Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders
- (2014) Hermine M. Dees-Ribbers et al. RADIOTHERAPY AND ONCOLOGY
- Characterization of Texture Features of Bladder Carcinoma and the Bladder Wall on MRI
- (2013) Zhengxing Shi et al. ACADEMIC RADIOLOGY
- Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
- (2013) Richard K. Lee et al. BJU INTERNATIONAL
- Advances in bladder cancer imaging
- (2013) Shaista Hafeez et al. BMC Medicine
- Comparison of adaptive radiotherapy techniques for the treatment of bladder cancer
- (2013) G J Webster et al. BRITISH JOURNAL OF RADIOLOGY
- Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
- (2013) Jeffrey J. Leow et al. EUROPEAN UROLOGY
- Intrafraction Bladder Motion in Radiation Therapy Estimated From Pretreatment and Posttreatment Volumetric Imaging
- (2013) Farshad Foroudi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
- (2013) Amanda Eustace et al. RADIOTHERAPY AND ONCOLOGY
- Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience
- (2012) Faysal A. Yafi et al. BJU INTERNATIONAL
- Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer
- (2012) Jens R. Laurberg et al. BJU INTERNATIONAL
- Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
- (2012) Richard E. Hautmann et al. EUROPEAN UROLOGY
- Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer
- (2012) Soichiro Yoshida et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
- (2012) Adrian S. Fairey et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial
- (2011) F. Cognetti et al. ANNALS OF ONCOLOGY
- Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness
- (2011) Shuichiro Kobayashi et al. EUROPEAN RADIOLOGY
- Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
- (2011) Ananya Choudhury et al. JOURNAL OF CLINICAL ONCOLOGY
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment
- (2011) Steven Christopher Smith et al. LANCET ONCOLOGY
- Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
- (2011) George J. Netto Nature Reviews Urology
- ‘Plan of the day’ adaptive radiotherapy for bladder cancer using helical tomotherapy
- (2011) Vedang Murthy et al. RADIOTHERAPY AND ONCOLOGY
- Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder
- (2010) Christian Bolenz et al. BJU INTERNATIONAL
- MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
- (2010) A. Choudhury et al. CANCER RESEARCH
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- The MRN complex in double-strand break repair and telomere maintenance
- (2010) Brandon J. Lamarche et al. FEBS LETTERS
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
- (2010) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and management of complications following radical cystectomy for bladder cancer
- (2010) Andreas Bohle International Braz J Urol
- Assessment of Bladder Motion for Clinical Radiotherapy Practice Using Cine–Magnetic Resonance Imaging
- (2009) Catherine A. McBain et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
- (2009) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
- T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival
- (2008) S. A. Boorjian et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation